-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Short Interest in Hyperfine, Inc. (NASDAQ:HYPR) Drops By 10.1%
Short Interest in Hyperfine, Inc. (NASDAQ:HYPR) Drops By 10.1%
Hyperfine, Inc. (NASDAQ:HYPR – Get Rating) saw a significant drop in short interest during the month of December. As of December 30th, there was short interest totalling 2,660,000 shares, a drop of 10.1% from the December 15th total of 2,960,000 shares. Currently, 5.5% of the shares of the company are short sold. Based on an average daily volume of 278,500 shares, the days-to-cover ratio is presently 9.6 days.
Hyperfine Trading Up 5.6 %
HYPR stock opened at $0.95 on Friday. The firm has a 50 day moving average of $0.84 and a 200-day moving average of $1.12. Hyperfine has a 12-month low of $0.68 and a 12-month high of $5.20.
Get Hyperfine alerts:Hyperfine (NASDAQ:HYPR – Get Rating) last posted its quarterly earnings results on Thursday, November 10th. The company reported ($0.19) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.26) by $0.07. Hyperfine had a negative net margin of 1,479.40% and a negative return on equity of 54.01%. The company had revenue of $2.35 million during the quarter, compared to the consensus estimate of $1.60 million. Sell-side analysts forecast that Hyperfine will post -1.1 earnings per share for the current fiscal year.
Insiders Place Their Bets
In related news, CMO Khan Siddiqui sold 1,039 shares of the firm's stock in a transaction dated Wednesday, November 16th. The stock was sold at an average price of $84.00, for a total transaction of $87,276.00. Following the transaction, the chief marketing officer now owns 85,080 shares of the company's stock, valued at $7,146,720. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other Hyperfine news, Director Jonathan M. Rothberg acquired 47,007 shares of the stock in a transaction on Tuesday, November 29th. The shares were bought at an average price of $0.72 per share, with a total value of $33,845.04. Following the acquisition, the director now owns 656,492 shares of the company's stock, valued at $472,674.24. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CMO Khan Siddiqui sold 1,039 shares of Hyperfine stock in a transaction that occurred on Wednesday, November 16th. The shares were sold at an average price of $84.00, for a total value of $87,276.00. Following the completion of the sale, the chief marketing officer now directly owns 85,080 shares in the company, valued at approximately $7,146,720. The disclosure for this sale can be found here. Over the last 90 days, insiders have bought 86,495 shares of company stock valued at $69,289 and have sold 5,161 shares valued at $90,738. Corporate insiders own 26.11% of the company's stock.Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of HYPR. Security Benefit Life Insurance Co. KS acquired a new position in shares of Hyperfine during the 3rd quarter worth approximately $2,025,000. Vanguard Group Inc. acquired a new position in Hyperfine in the 1st quarter valued at $6,237,000. Alphabet Inc. acquired a new position in Hyperfine in the 3rd quarter valued at $728,000. BlackRock Inc. acquired a new position in Hyperfine in the 1st quarter valued at $2,042,000. Finally, State Street Corp acquired a new position in Hyperfine in the 1st quarter valued at $378,000. 27.65% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Separately, B. Riley began coverage on Hyperfine in a report on Tuesday, October 4th. They issued a "buy" rating and a $3.50 price objective on the stock.
About Hyperfine
(Get Rating)
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products. The company's products include Swoop Portable MR imaging system, which offers neuroimaging at the point of care, as well as informs the timely diagnosis and treatment of acute conditions in a wide range of clinical settings.
Featured Stories
- Get a free copy of the StockNews.com research report on Hyperfine (HYPR)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.
Hyperfine, Inc. (NASDAQ:HYPR – Get Rating) saw a significant drop in short interest during the month of December. As of December 30th, there was short interest totalling 2,660,000 shares, a drop of 10.1% from the December 15th total of 2,960,000 shares. Currently, 5.5% of the shares of the company are short sold. Based on an average daily volume of 278,500 shares, the days-to-cover ratio is presently 9.6 days.
空头股数(纳斯达克代码:HYPR-GET Rating)12月份空头股数销量大幅下降。截至12月30日,空头股数共有266万股,与12月15日的296万股相比,下降了10.1%。目前,该公司5.5%的股份被卖空。以日均成交量27.85万股计算,目前天数与回补比率为9.6天。
Hyperfine Trading Up 5.6 %
超精细交易上涨5.6%
HYPR stock opened at $0.95 on Friday. The firm has a 50 day moving average of $0.84 and a 200-day moving average of $1.12. Hyperfine has a 12-month low of $0.68 and a 12-month high of $5.20.
上周五,HYPR的股价开盘报0.95美元。该公司的50日移动均线切入位在0.84美元,200日移动均线切入位在1.12美元。超级罚款为0.68美元,为12个月低点,12个月高位为5.20美元。
Hyperfine (NASDAQ:HYPR – Get Rating) last posted its quarterly earnings results on Thursday, November 10th. The company reported ($0.19) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.26) by $0.07. Hyperfine had a negative net margin of 1,479.40% and a negative return on equity of 54.01%. The company had revenue of $2.35 million during the quarter, compared to the consensus estimate of $1.60 million. Sell-side analysts forecast that Hyperfine will post -1.1 earnings per share for the current fiscal year.
超精细(纳斯达克:HYPR-GET Rating)上一次公布季度收益是在11月10日星期四。该公司公布本季度每股收益(EPS)为0.19美元,比分析师普遍预期的0.26美元高出0.07美元。超级罚款的净利润率为负1,479.40%,净资产回报率为负54.01%。该公司本季度营收为235万美元,而市场普遍预期为160万美元。卖方分析师预测,超罚款将公布本财年的每股收益为1.1美元。
Insiders Place Their Bets
内部人士下注
Institutional Inflows and Outflows
机构资金流入和流出
Several institutional investors have recently modified their holdings of HYPR. Security Benefit Life Insurance Co. KS acquired a new position in shares of Hyperfine during the 3rd quarter worth approximately $2,025,000. Vanguard Group Inc. acquired a new position in Hyperfine in the 1st quarter valued at $6,237,000. Alphabet Inc. acquired a new position in Hyperfine in the 3rd quarter valued at $728,000. BlackRock Inc. acquired a new position in Hyperfine in the 1st quarter valued at $2,042,000. Finally, State Street Corp acquired a new position in Hyperfine in the 1st quarter valued at $378,000. 27.65% of the stock is currently owned by institutional investors and hedge funds.
几家机构投资者最近调整了对HYPR的持股。安全福利人寿保险公司KS在第三季度收购了价值约2,025,000美元的超级罚款股票的新头寸。先锋集团(Vanguard Group Inc.)在第一季度收购了一个新的超罚款头寸,估值为6,237,000美元。Alphabet在第三季度收购了价值728,000美元的超级罚款新头寸。贝莱德股份有限公司在第一季度获得了一个新的超级罚款头寸,估值为2,042,000美元。最后,道富集团在第一季度获得了一个新的超罚款头寸,估值为37.8万美元。27.65%的股票目前由机构投资者和对冲基金持有。
Wall Street Analysts Forecast Growth
华尔街分析师预测经济增长
Separately, B. Riley began coverage on Hyperfine in a report on Tuesday, October 4th. They issued a "buy" rating and a $3.50 price objective on the stock.
另外,B.莱利在10月4日星期二的一份报告中开始报道超级罚款。他们对该股的评级为“买入”,目标价为3.5美元。
About Hyperfine
关于超精细
(Get Rating)
(获取评级)
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products. The company's products include Swoop Portable MR imaging system, which offers neuroimaging at the point of care, as well as informs the timely diagnosis and treatment of acute conditions in a wide range of clinical settings.
Hyperfiny,Inc.是一家医疗设备公司,提供磁共振成像(MRI)产品。该公司的产品包括Swoop便携式磁共振成像系统,该系统在护理点提供神经成像,并在广泛的临床环境中及时诊断和治疗急性疾病。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on Hyperfine (HYPR)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
- 免费获取StockNews.com关于超精细的研究报告(HYPR)
- 市场回顾周-1/16-1/20
- Old Dominion是否表明Trucking正在踩刹车?
- 诺德斯特龙对零售业降价的担忧
- 埃克森美孚股票:在Buy Point附近
- 高股息率的必和必拓认为中国推动了23年的增长
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.
接受超精品日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收最新新闻和分析师对Hyperfining及相关公司评级的每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧